END-AF 1 (Recruiting) Clinical randomised Phase II trial of AP31969 versus Placebo for Rhythm control of atrial fibrillation Medicine AP31969 Population Arrhythmia Phase II Starting year 2025 Director of Study dr. R.G. Tieleman (Cardioloog) Groningen, Martini Ziekenhuis
